Evidence map›Paper›PMID 32202609›Full record

ArticleJAMA internal medicine2020

Association Between Medicaid Expansion and Rates of Opioid-Related Hospital Use.

Hefei Wen, Aparna Soni, Alex Hollingsworth, Seth Freedman, Joseph Benitez, Kosali Simon, Brendan Saloner

Abstract read
In one paragraph

Article in JAMA internal medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Hefei WenHarvard Pilgrim Health Care Institute, Division of Health Policy and Insurance Research, Department of Population Medicine, Harvard Medical School, Boston, Massachusetts.
Aparna SoniSchool of Public Affairs, Department of Public Administration and Policy, American University, Washington, DC.
Alex HollingsworthO'Neill School of Public and Environmental Affairs, Indiana University, Bloomington, Indiana.
Seth FreedmanO'Neill School of Public and Environmental Affairs, Indiana University, Bloomington, Indiana.
Joseph BenitezCollege of Public Health, Department of Health Management & Policy, University of Kentucky, Lexington, Kentucky.
Kosali SimonO'Neill School of Public and Environmental Affairs, Indiana University, Bloomington, Indiana.
Brendan SalonerDepartment of Health Policy and Management, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland.

Funding

Improving Access and Quality of care for Medicaid-Eligible Adults with Opioid Use DisorderK01DA042139 · NIDA · JOHNS HOPKINS UNIVERSITY · PI SALONER, BRENDAN K · 2017 to 2021
$917k
NIDA NIH HHS K01 DA042139
6 · The paper itself

Abstract

Importance: The rate of opioid-related emergency department (ED) visits and inpatient hospitalizations has increased rapidly in recent years. Medicaid expansions have the potential to reduce overall opioid-related hospital events by improving access to outpatient treatment for opioid use disorder. Objective: To examine the association between Medicaid expansions and rates of opioid-related ED visits and inpatient hospitalizations. Design, Setting, and Participants: A difference-in-differences observational design was used to compare changes in opioid-related hospital events in US nonfederal, nonrehabilitation hospitals in states that implemented Medicaid expansions between the first quarter of 2005 and the last quarter of 2017 with changes in nonexpansion states. All-payer ED and hospital discharges from 45 states in the Healthcare Cost and Utilization Project FastStats were included. Exposures: State implementation of Medicaid expansions between 2005 and 2017. Main Outcomes and Measures: Rates of all opioid-related ED visits and inpatient hospitalizations, measured as the quarterly numbers of treat-and-release ED discharges and hospital discharges related to opioid abuse, dependence, and overdose, per 100 000 state population. Results: In the 46 states and District of Columbia included in the study, 1524 observations of emergency department data and 2219 observations of opioid-related inpatient hospitalizations were analyzed. The post-2014 Medicaid expansions were associated with a 9.74% (95% CI, -18.83% to -0.65%) reduction in the rate of opioid-related inpatient hospitalizations. There appeared to be no association between the pre-2014 or post-2014 Medicaid expansions and the rate of opioid-related ED visits (post-2014 Medicaid expansions, -3.98%; 95% CI, -14.69% to 6.72%; and pre-2014 Medicaid expansions, 1.02%; 95% CI, -5.25% to 7.28%). Conclusions and Relevance: Medicaid expansion appears to be associated with meaningful reductions in opioid-related hospital use, possibly attributable to improved care for opioid use disorder in other settings.

Indexed as

HospitalizationMedicaidPatient Protection and Affordable Care ActAnalgesics, OpioidEmergency Service, HospitalHumansMedically UninsuredOpioid-Related DisordersUnited StatesAnalgesics, Opioid

Identifiers

PMID32202609
PMCPMC7091455

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.